Bosentan for the Treatment of Human Immunodeficiency Virus–associated Pulmonary Arterial Hypertension-Reference-Cited by-同舟云学术

Bosentan for the Treatment of Human Immunodeficiency Virus–associated Pulmonary Arterial Hypertension

Published:2004-12 Issue:11 Volume:170 Page:1212-1217
ISSN:1073-449X
Container-title:American Journal of Respiratory and Critical Care Medicine
language:en
Short-container-title:Am J Respir Crit Care Med

Author:

Sitbon Olivier,Gressin Virginie,Speich Rudolf,Macdonald Peter S.,Opravil Milos,Cooper David A.,Fourme Thierry,Humbert Marc,Delfraissy Jean-François,Simonneau Gérald

Publisher

American Thoracic Society

Subject

Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine

Reference31 articles.

1. RISK FACTORS FOR PULMONARY ARTERIAL HYPERTENSION

2. HIV-associated primary pulmonary hypertension. A case control study. Swiss HIV Cohort Study.

3. Primary Pulmonary Hypertension in HIV Infection

4. HIV-Related Pulmonary Hypertension

5. Prognostic Factors for Survival in Human Immunodeficiency Virus–associated Pulmonary Arterial Hypertension

Cited by 206 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment algorithm for pulmonary arterial hypertension;European Respiratory Journal;2024-08-29

2. Eurasian guidelines for the diagnosis and treatment of pulmonary hypertension (2023);Eurasian heart journal;2024-03-11

3. Contribution of pressure and flow changes to resistance reduction after pulmonary arterial hypertension treatment: a meta-analysis of 3898 patients;ERJ Open Research;2023-12-07

4. Advanced Lung Disease;Textbook of Transplantation and Mechanical Support for End‐Stage Heart and Lung Disease;2023-09-08

5. Human Endogenous Retrovirus, SARS-CoV-2, and HIV Promote PAH via Inflammation and Growth Stimulation;International Journal of Molecular Sciences;2023-04-18